Ivermectin not to be included in Centre’s coronavirus management protocol
The experts of ICMR’s National Task Force for Covid-19 and the Joint Monitoring Group held its meeting on Thursday to deliberate on whether the drug should be included in the national treatment guidelines
Ivermectin, an antiparasitic drug, being touted as a possible treatment for the coronavirus infection will not be included in the Health Ministry’s Clinical Management Protocol for Covid-19, sources said on Thursday.
Experts decided not to include Ivermectin in the national clinical management protocol for Covid-19 because of lack of sufficient evidence on its efficacy (Biplov Bhuyan/HT PHOTO)
{{^htLoading}} {{/htLoading}}
Some states including Uttar Pradesh are already using the drug off-label not only as a treatment option but also as a prophylaxis against Covid-19, a source said.
Already widely used against intestinal parasites and scabies, it is relatively a safe and cheap drug.
The experts of The Indian Council of Medical Research(ICMR’s) National Task Force for Covid-19 and the Joint Monitoring Group held its meeting on Thursday to deliberate on whether the drug should be included in the national treatment guidelines.
“Following deliberations, experts decided not to include Ivermectin in the national clinical management protocol for Covid-19 because of lack of sufficient evidence on its efficacy based on randomised trials held in India and abroad,” a source said.The Health Ministry has allowed the use of Remdesivir for restricted emergency use purposes in moderate cases under “investigational therapies” in the Clinical Management Protocol for Covid-19.
{{^htLoading}} {{/htLoading}}
{{^usCountry}}
The ministry has also okayed off-label application of Tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating Covid-19 patients in moderate stage of the illness as “investigational therapies”.
{{/usCountry}}
{{#usCountry}}
The ministry has also okayed off-label application of Tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating Covid-19 patients in moderate stage of the illness as “investigational therapies”.
{{/usCountry}}
It also recommended Hydroxychloroquine for patients during the early course of the disease but not for critically ill ones.The centre has also included an inexpensive, widely used steroid Dexamethasone in treatment protocols for Covid-19 patients in the moderate to severe stages of their illness among other therapeutic measures.
The ministry advised use of Dexamethasone, which is already used in a wide range of conditions for its anti-inflammatory and immunosuppressant effects, as an alternative choice to Methylprednisolone for managing moderate to severe cases of coronavirus infection.
Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.
Get real-time updates on CJP Delhi Protest LIVE , breaking headlines, and top India News, breaking headlines, and real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
Get real-time updates on CJP Delhi Protest LIVE , breaking headlines, and top India News, breaking headlines, and real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
